Vasopressin Analogues


Vasopressin analogues are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that mimic the actions of the hormone vasopressin in the human body. Vasopressin, also known as antidiuretic hormone (ADH), plays a crucial role in regulating fluid balance and blood pressure.

These analogues are developed by modifying the structure of vasopressin to enhance its therapeutic properties. They act on specific vasopressin receptors located in various tissues, including the kidneys, blood vessels, and brain. By interacting with these receptors, vasopressin analogues exert a range of effects.

One of the key applications of vasopressin analogues is the treatment of diabetes insipidus, a condition characterized by excessive urine production and excessive thirst. By stimulating the vasopressin receptors in the kidneys, these analogues promote water reabsorption and reduce urine output.

Vasopressin analogues are also utilized in critical care settings to manage hypotension (low blood pressure) and vasodilatory shock. By binding to vasopressin receptors on blood vessels, these analogues induce vasoconstriction, which helps to elevate blood pressure and improve perfusion to vital organs.

In summary, vasopressin analogues are an important class of pharmaceutical APIs that modulate vasopressin receptor activity. Their therapeutic applications range from treating diabetes insipidus to managing hypotension in critical care. By optimizing the structure of vasopressin, these analogues provide targeted and effective treatments for various medical conditions.

NameCAS number
Terlipressin14636-12-5
Vasopressin11000-17-2